Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study. [PDF]
Gupta V +17 more
europepmc +1 more source
Back to biology: new insights on inheritance in myeloproliferative disorders. [PDF]
Braunstein EM, Moliterno AR.
europepmc +1 more source
NPV-BSK805, an Antineoplastic Jak2 Inhibitor Effective in Myeloproliferative Disorders, Causes Adiposity in Mice by Interfering With the Action of Leptin. [PDF]
Haissaguerre M +5 more
europepmc +1 more source
FAS/FASL gene polymorphisms in Turkish patients with chronic myeloproliferative disorders. [PDF]
Ozdemirkiran FG +6 more
europepmc +1 more source
Disfiguring Nodular Cephalic Xanthoma Disseminatum: An Exceptional Variant of a Forgotten Entity
Arturo Bonometti +7 more
doaj +1 more source
Myeloid/lymphoid neoplasm with FLT3 gene fusion: report of a case with a novel t(5;13)(q13;q12) SSBP2::FLT3 fusion. [PDF]
Cook JR +6 more
europepmc +1 more source
Carotid Pseudoaneurysm Repair in a Patient with Myeloproliferative Disorder Complicated by Contralateral Stroke, Graft Thrombosis, Pyoderma Gangrenosum, and Superinfection: A Case Report. [PDF]
Voica C +9 more
europepmc +1 more source
Clinical and hematological profile of patients with philadelphia-negative myeloproliferative neoplasms: First report from the Ecuadorian registry. [PDF]
Freire C +8 more
europepmc +1 more source

